Utpal Singh
- Role
-
Executive Vice President, Chief Scientific Officer
- Location
-
Søborg, Denmark
Experience
Utpal was appointed to the position of Chief Scientific Officer at Zealand Pharma in April 2025. He brings nearly 25 years of industry experience that spans the full drug discovery and development lifecycle. Most recently, Utpal served as Senior Vice President of Small Molecule Discovery at Eli Lilly and Company, where he led the transformation of the discovery engine by building new capabilities and strategic partnerships to advance a focused portfolio. His team contributed to the discovery of numerous clinical candidates across multiple therapeutic areas. Utpal began his pharmaceutical career in 2001 with Merck & Co following completion of a postdoctoral fellowship in organic chemistry at the Massachusetts Institute of Technology.
Education
He holds a PhD in chemical engineering from The Pennsylvania State University and a BS in chemical engineering from Purdue University.
